» Articles » PMID: 38399379

Bioavailability of Oral Curcumin in Systematic Reviews: A Methodological Study

Overview
Publisher MDPI
Specialty Chemistry
Date 2024 Feb 24
PMID 38399379
Authors
Affiliations
Soon will be listed here.
Abstract

Curcumin is a natural compound found in turmeric that exhibits diverse biological activities. However, its poor bioavailability limits its therapeutic application, which has led to the development of various bioavailability-improved formulations. In this methodological study, we analyzed whether systematic reviews on curcumin considered the bioavailability of systemic oral curcumin formulations when synthesizing evidence from human clinical trials. A total of 171 systematic reviews published between 2003 and 2022 were included in the study. From the included studies, we extracted data on study characteristics; type of curcumin; methods; and reporting regarding bioavailability, funding, and conflict of interest. Our results show that systematic reviews rarely consider the variable bioavailability of tested curcumin formulations. Relevant statistical subgroup and/or sensitivity analyses were reported in the methods and results of only 3.5% and 6.4% of reviews, respectively. However, more reviews mentioned bioavailability in their discussion (57%) or conclusion (13%). The detailed analysis of the included systematic reviews suggests that there is broad recognition of product bioavailability as a crucial factor affecting the health effects of curcumin, which is not accompanied by adequate evidence synthesis. Therefore, the results of most systematic reviews on orally administered curcumin should be taken with caution.

Citing Articles

The Therapeutic Effects of Curcumin on Oral Disease: A Systematic Review.

Indriyani N, Nuraeny N Clin Pharmacol. 2025; 17:13-24.

PMID: 40034679 PMC: 11874755. DOI: 10.2147/CPAA.S506396.


Fmoc-FF Nanogel-Mediated Delivery of Doxorubicin and Curcumin in Thyroid Cancer Cells.

Gallo E, Smaldone G, Cimmino L, Braile M, Orlandella F, Luciano N Pharmaceutics. 2025; 17(2).

PMID: 40006633 PMC: 11858838. DOI: 10.3390/pharmaceutics17020263.


A Review on Current Aspects of Curcumin-Based Effects in Relation to Neurodegenerative, Neuroinflammatory and Cerebrovascular Diseases.

Moldoveanu C, Tomoaia-Cotisel M, Sevastre-Berghian A, Tomoaia G, Mocanu A, Pal-Racz C Molecules. 2025; 30(1.

PMID: 39795101 PMC: 11722367. DOI: 10.3390/molecules30010043.


Activation of cannabinoid receptor 2 by turmeric oleoresin reduces inflammation and oxidative stress in an osteoarthritis model.

Ghiselli F, Majer R, Piva A, Grilli E Front Pharmacol. 2024; 15:1488254.

PMID: 39717553 PMC: 11664362. DOI: 10.3389/fphar.2024.1488254.


Biocompatible Poly(ε-Caprolactone) Nanocapsules Enhance the Bioavailability, Antibacterial, and Immunomodulatory Activities of Curcumin.

DAngeli F, Granata G, Romano I, Distefano A, Lo Furno D, Spila A Int J Mol Sci. 2024; 25(19).

PMID: 39409022 PMC: 11476408. DOI: 10.3390/ijms251910692.


References
1.
Al-Karawi D, Al Mamoori D, Tayyar Y . The Role of Curcumin Administration in Patients with Major Depressive Disorder: Mini Meta-Analysis of Clinical Trials. Phytother Res. 2015; 30(2):175-83. DOI: 10.1002/ptr.5524. View

2.
Pan-On S, Dilokthornsakul P, Tiyaboonchai W . Trends in advanced oral drug delivery system for curcumin: A systematic review. J Control Release. 2022; 348:335-345. DOI: 10.1016/j.jconrel.2022.05.048. View

3.
Gupta T, Singh J, Kaur S, Sandhu S, Singh G, Kaur I . Enhancing Bioavailability and Stability of Curcumin Using Solid Lipid Nanoparticles (CLEN): A Covenant for Its Effectiveness. Front Bioeng Biotechnol. 2020; 8:879. PMC: 7593682. DOI: 10.3389/fbioe.2020.00879. View

4.
Ma Z, Wang N, He H, Tang X . Pharmaceutical strategies of improving oral systemic bioavailability of curcumin for clinical application. J Control Release. 2019; 316:359-380. DOI: 10.1016/j.jconrel.2019.10.053. View

5.
Shokri-Mashhadi N, Bagherniya M, Askari G, Sathyapalan T, Sahebkar A . A Systematic Review of the Clinical Use of Curcumin for the Treatment of Osteoarthritis. Adv Exp Med Biol. 2021; 1291:265-282. DOI: 10.1007/978-3-030-56153-6_16. View